1. Home
  2. VIR vs UWMC Comparison

VIR vs UWMC Comparison

Compare VIR & UWMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • UWMC
  • Stock Information
  • Founded
  • VIR 2016
  • UWMC 1986
  • Country
  • VIR United States
  • UWMC United States
  • Employees
  • VIR N/A
  • UWMC N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • UWMC Finance: Consumer Services
  • Sector
  • VIR Health Care
  • UWMC Finance
  • Exchange
  • VIR Nasdaq
  • UWMC Nasdaq
  • Market Cap
  • VIR 706.4M
  • UWMC 1.4B
  • IPO Year
  • VIR 2019
  • UWMC N/A
  • Fundamental
  • Price
  • VIR $5.04
  • UWMC $6.55
  • Analyst Decision
  • VIR Strong Buy
  • UWMC Hold
  • Analyst Count
  • VIR 11
  • UWMC 7
  • Target Price
  • VIR $25.73
  • UWMC $5.54
  • AVG Volume (30 Days)
  • VIR 1.5M
  • UWMC 8.2M
  • Earning Date
  • VIR 10-30-2025
  • UWMC 11-06-2025
  • Dividend Yield
  • VIR N/A
  • UWMC 5.97%
  • EPS Growth
  • VIR N/A
  • UWMC 112.84
  • EPS
  • VIR N/A
  • UWMC 0.07
  • Revenue
  • VIR $19,000,000.00
  • UWMC $2,622,828,000.00
  • Revenue This Year
  • VIR N/A
  • UWMC $25.96
  • Revenue Next Year
  • VIR $11.08
  • UWMC N/A
  • P/E Ratio
  • VIR N/A
  • UWMC $101.16
  • Revenue Growth
  • VIR N/A
  • UWMC 13.45
  • 52 Week Low
  • VIR $4.16
  • UWMC $3.80
  • 52 Week High
  • VIR $14.45
  • UWMC $9.17
  • Technical
  • Relative Strength Index (RSI)
  • VIR 52.27
  • UWMC 65.10
  • Support Level
  • VIR $4.75
  • UWMC $5.50
  • Resistance Level
  • VIR $5.07
  • UWMC $7.09
  • Average True Range (ATR)
  • VIR 0.28
  • UWMC 0.24
  • MACD
  • VIR -0.01
  • UWMC -0.00
  • Stochastic Oscillator
  • VIR 34.91
  • UWMC 64.94

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About UWMC UWM Holdings Corporation

UWM Holdings Corp engages in the origination, sale, and servicing of residential mortgage loans in the wholesale channel. The company provides independent mortgage advisors across the states and the district of Columbia.

Share on Social Networks: